Guidelines for conscious sedation and monitoring during gastrointestinal endoscopy.
This is one of a series of statements discussing the utilization of GI endoscopy in common clinical situations. The Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy prepared this text. In preparing this guideline, a MEDLINE literature search was performed, and additional references were obtained from the bibliographies of the identified articles and from recommendations of expert consultants. When little or no data exist from well-designed prospective trials, emphasis is given to results from large series and reports from recognized experts. Guidelines for appropriate utilization of endoscopy are based on a critical review of the available data and expert consensus. Further controlled clinical studies are needed to clarify aspects of this statement, and revision may be necessary as new data appear. Clinical consideration may justify a course of action at variance to these recommendations.
Waring
J Patrick
JP
Baron
Todd H
TH
Hirota
William K
WK
Goldstein
Jay L
JL
Jacobson
Brian C
BC
Leighton
Jonathan A
JA
Mallery
J Shawn
JS
Faigel
Douglas O
DO
D000768:Anesthesia, General; D000779:Anesthetics, Local; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D016292:Procedural Sedation / Q000592:standards; D004329:Droperidol / Q000627:therapeutic use; D016099:Endoscopy, Gastrointestinal / Q000592:standards; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage; D008991:Monitoring, Physiologic / Q000592:standards; D009292:Narcotic Antagonists / Q000627:therapeutic use; D009294:Narcotics / Q000627:therapeutic use; D010614:Pharynx / Q000187:drug effects; D014149:Tranquilizing Agents / Q000627:therapeutic use
D000779:Anesthetics, Local; D014151:Anti-Anxiety Agents; D006993:Hypnotics and Sedatives; D009292:Narcotic Antagonists; D009294:Narcotics; D014149:Tranquilizing Agents; D001569:Benzodiazepines; D004329:Droperidol